NCT07618195Recruiting
Core cell-therapy study
Study of EPI-001 in androgenetic alopecia
- Sponsor
- Epibiotech
- Stage
- Phase I / II
- Enrollment
- 42 estimated
- Timeline
- Started Jan 2026 · completion estimated Jun 2029
- Intervention
- Autologous dermal papilla cells injected into the scalp
- Reported focus
- Safety, tolerability and hair-growth measures
Registry verified 18 Aug 2026
View registry record ↗Read related analysis →NCT07107841Recruiting
Adjacent secretome study
Autologous hair-follicle secretome for androgenetic alopecia
- Sponsor
- Acorn Biolabs
- Stage
- Not applicable
- Enrollment
- 60 estimated
- Timeline
- Started Oct 2025 · completion estimated Sep 2027
- Intervention
- Autologous hair-follicle-derived secretome injected into the scalp
- Reported focus
- Hair counts, safety, density, thickness and participant-reported change
Registry verified 18 Aug 2026
View registry record ↗Read related analysis →NCT01286649Completed
Historical cell-therapy study
Autologous hair-follicle cells for androgenetic alopecia
- Sponsor
- TrichoScience Innovations / RepliCel lineage
- Stage
- Phase I / II
- Enrollment
- 19 actual
- Timeline
- Started Dec 2010 · completed Feb 2017
- Intervention
- Autologous hair-follicle cells versus cell-medium control
- Reported focus
- Long-term safety and exploratory hair-growth assessment
Registry verified 18 Aug 2026
View registry record ↗Read related analysis →Important: ClinicalTrials.gov is a registry. Listing a study does not establish government approval, scientific validity or a positive result.
Professional use
See how registry changes would be reported
The sample professional brief distinguishes a registry update from a clinical result, regulatory decision or commercial milestone.
Registry monitoring
Receive material trial-status changes
Updates are issued monthly or when a registry or publication changes the evidence assessment.